Medical devices, healthcare technology and the business of care
510(k) clearance · K261977

Braun Aura 9 (6042)

Cyden Limited · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONK261977

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 25 September 2026 for Braun Aura 9 (6042), submitted by Cyden Limited of Swansea, GB, under 510(k) number K261977. The application was received on 12 June 2026. The device falls under classification product code OHT, light based over-the-counter hair removal, regulation number 878.4810, with the General & Plastic Surgery medical specialty and review panel.

A SESE decision means the FDA cleared the submission as substantially equivalent to a legally marketed predicate device; it is not a premarket approval. The public record lists a special summary, no third-party review, no combination product status and no authorized predetermined change control plan. The page does not describe the specific device components, the predicate device, or the basis for the equivalence finding, so those details remain unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 25, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261977
Regulatory pathway
510(k) premarket notification
Applicant
Cyden Limited
Product code
OHT
Decision code
SESE
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Light Based Over-The-Counter Hair Removal.

Applicant
Cyden Limited
Product code
OHT
FDA device class
2

FDA decision timeline

  1. K261977 received

    Application receipt date recorded by FDA.

  2. K261977 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OHT

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cyden Limited

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Swansea

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records